|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7170 EUR | +4.82% |
|
-17.24% | +326.06% |
| 07-16 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
| 07-16 | Valerio Therapeutics, Abivax Sign R&D Deal for Inflammatory Diseases' Drug Candidates | MT |
Quotes 5-day view: Valerio Therapeutics
Delayed Quote Deutsche Boerse AG
| 03/08/2026 | 04/08/2026 | 05/08/2026 | 06/08/2026 | 07/08/2026 | |
|---|---|---|---|---|---|
| Last | €0.7500 | €0.7010 | €0.6960 | €0.6840 | €0.6050 |
| Volume | 8,000 | 0 | 0 | 0 | 0 |
| Change | +2.60% | -6.53% | -0.71% | -1.72% | +4.82% |
| Opening | €0.7260 | €0.7290 | €0.6960 | €0.6840 | €0.6050 |
| High | €0.7500 | €0.7290 | €0.6960 | €0.6840 | €0.6050 |
| Low | €0.7260 | €0.7010 | €0.6960 | €0.6840 | €0.6050 |
Performance
| 1 day | +4.82% | ||
| 1 week | -17.24% | ||
| Current month | -17.24% | ||
| 1 month | +45.78% | ||
| 3 months | +303.33% | ||
| 6 months | +343.22% | ||
| Current year | +326.06% | ||
| 1 year | +839.44% | ||
| 3 years | +175.00% | ||
| 5 years | +4.85% | ||
| 10 years | -80.70% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
309,657,946
Market Cap (USD)
356,831,005
Net sales ()
2,573,000
Net sales (USD)
2,964,969
Number of employees
25
Sales / Employee (EUR)
102,920
Sales / Employee (USD)
118,599
Free-Float
64.77 %
Free-Float capitalization (EUR)
200,573,412
Free-Float capitalization (USD)
231,128,614
Average Daily Capital Traded
0%
Indicators
Moving average 5 days
0.7124
Moving average 20 days
0.6608
Moving average 50 days
0.395
Moving average 100 days
0.2707
Price spread / (MMA5)
-0.64%
Price spread / (MMA20)
-7.84%
Price spread / (MMA50)
-44.91%
Price spread / (MMA100)
-62.25%
RSI 9 days
52.6
RSI 14 days
56.87
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.82% | -17.24% | +839.44% | +175.00% | 357M | |
| +1.89% | +3.20% | +59.70% | +165.18% | 1,062B | |
| -0.24% | +0.45% | +50.64% | +52.02% | 619B | |
| -0.95% | -5.26% | +24.23% | +65.08% | 431B | |
| +1.77% | +5.06% | +49.14% | +40.27% | 358B | |
| +0.99% | -0.13% | +35.88% | +40.72% | 293B | |
| +1.27% | -5.08% | +9.50% | +10.14% | 247B | |
| -0.73% | +4.44% | +42.22% | +66.41% | 219B | |
| +3.71% | -0.52% | -1.28% | -44.13% | 200B | |
| -0.68% | -0.32% | +18.66% | +66.32% | 162B | |
| Average | +1.40% | -1.90% | +112.81% | +63.70% | 359.26B | |
| Weighted average by Cap. | +0.73% | -0.83% | +41.19% | +78.25% |
Historical Quotes: Valerio Therapeutics
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 0.6 |  | 0.75 |
| 1 month | 0.38 | | 0.93 |
| Current year | 0.09 | | 0.93 |
| 1 year | 0.04 | | 0.93 |
| 3 years | 0.03 | | 0.93 |
| 5 years | 0.03 | | 0.93 |
| 10 years | 0.03 | | 5.38 |
Monthly variations
Annual variations
| 2026 | +381.69% | ||
| 2025 | +71.29% | ||
| 2024 | -45.28% | ||
| 2023 | +25.21% | ||
| 2022 | -70.34% | ||
| 2021 | -38.55% | ||
| 2020 | +29.43% | ||
| 2019 | -39.36% | ||
| 2018 | -20.93% | ||
| 2017 | -56.66% | ||
| 2016 | -32.71% | ||
| 2015 | -29.50% | ||
| 2014 | +22.30% | ||
| 2013 | -9.31% | ||
| 2012 | +47.83% | ||
| 2011 | -41.33% | ||
| 2010 | +17.61% | ||
| 2009 | +108.14% | ||
| 2008 | -83.38% | ||
| 2007 | +18.01% | ||
| 2006 | -14.36% | ||
| 2005 | -1.79% |
- Stock Market
- Stocks
- ALVIO Stock
- C4X Stock
- Quotes Valerio Therapeutics
Select your edition
All financial news and data tailored to specific country editions
